| EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements 08.05.2023 / 12:58 CET/CEST Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed: Report Type: Quarterly financial report within the 1st half-year (Q1) Language: German Date of disclosure: May 15, 2023 Address: https://ir.dermapharm.de/de/investor-relations/#tagline-19857 Language: English Date of disclosure: May 15, 2023 Address: https://ir.dermapharm.de/en/investor-relations/#tagline-19876 08.05.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com |
| Language: | English |
| Company: | Dermapharm Holding SE |
| Lil-Dagover-Ring 7 | |
| 82031 Grünwald | |
| Germany | |
| Internet: | ir.dermapharm.de |
| End of News | EQS News Service |
| |
1626569 08.05.2023 CET/CEST
